ATE452141T1 - Neue proteine, z.b. zur verwendung für die in- vitro-isolierung und prävention von legionella pneumophila-infektionen - Google Patents

Neue proteine, z.b. zur verwendung für die in- vitro-isolierung und prävention von legionella pneumophila-infektionen

Info

Publication number
ATE452141T1
ATE452141T1 AT05778855T AT05778855T ATE452141T1 AT E452141 T1 ATE452141 T1 AT E452141T1 AT 05778855 T AT05778855 T AT 05778855T AT 05778855 T AT05778855 T AT 05778855T AT E452141 T1 ATE452141 T1 AT E452141T1
Authority
AT
Austria
Prior art keywords
legionella pneumophila
prevention
polynucleotides
new proteins
vitro isolation
Prior art date
Application number
AT05778855T
Other languages
English (en)
Inventor
Jean-Philippe Arie
Camille Cyncynatus
Original Assignee
Ingen Biosciences
Univ Claude Bernard Lyon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ingen Biosciences, Univ Claude Bernard Lyon filed Critical Ingen Biosciences
Application granted granted Critical
Publication of ATE452141T1 publication Critical patent/ATE452141T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT05778855T 2004-08-06 2005-06-21 Neue proteine, z.b. zur verwendung für die in- vitro-isolierung und prävention von legionella pneumophila-infektionen ATE452141T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0408714A FR2874025B1 (fr) 2004-08-06 2004-08-06 Nouvelles proteines permettant, notamment, la mise en evidence in vitro et la prevention des infections a legionella pneumophila
PCT/FR2005/001549 WO2006027431A1 (fr) 2004-08-06 2005-06-21 Nouvelles proteines permettant, notamment, la mise en evidence in vitro et la prevention des infections a legionella pneumophila

Publications (1)

Publication Number Publication Date
ATE452141T1 true ATE452141T1 (de) 2010-01-15

Family

ID=34949347

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05778855T ATE452141T1 (de) 2004-08-06 2005-06-21 Neue proteine, z.b. zur verwendung für die in- vitro-isolierung und prävention von legionella pneumophila-infektionen

Country Status (7)

Country Link
US (1) US7704697B2 (de)
EP (1) EP1781691B1 (de)
AT (1) ATE452141T1 (de)
CA (1) CA2576241A1 (de)
DE (1) DE602005018369D1 (de)
FR (1) FR2874025B1 (de)
WO (1) WO2006027431A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2895519B1 (fr) * 2005-12-28 2008-12-19 Abag Sa Utilisation de la proteine 5e2 dans le diagnostic in vitro d'infection a legionella pneumophila
FR2930646B1 (fr) * 2008-04-29 2012-09-07 Abag Detection, in vitro, d'anticorps produits a la suite d'une infection a legionella pneumophila
US8785145B2 (en) 2011-08-11 2014-07-22 Ingen Biosciences Method for diagnosing gram-negative infections

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6248329B1 (en) * 1998-06-01 2001-06-19 Ramaswamy Chandrashekar Parasitic helminth cuticlin nucleic acid molecules and uses thereof
FR2862659B1 (fr) * 2003-11-21 2006-02-10 Pasteur Institut Genome de legionella pneumophila souche paris- applications diagnostiques et epidemiologiques

Also Published As

Publication number Publication date
FR2874025B1 (fr) 2006-10-27
US20080260767A1 (en) 2008-10-23
FR2874025A1 (fr) 2006-02-10
DE602005018369D1 (de) 2010-01-28
EP1781691B1 (de) 2009-12-16
CA2576241A1 (fr) 2006-03-16
US7704697B2 (en) 2010-04-27
EP1781691A1 (de) 2007-05-09
WO2006027431A1 (fr) 2006-03-16

Similar Documents

Publication Publication Date Title
MX348154B (es) Anticuerpos de enlace a il-1-beta y fragmentos de los mismos.
NZ591415A (en) Haemophilus influenzae type B
TNSN08064A1 (en) Albumin fusion proteins
WO2007064917A3 (en) Methods of preparation of recombinant forms of human beta-amyloid protein and uses of these proteins
EA200901430A1 (ru) Варианты фермента аспарагиназы и их применение
MX2009004243A (es) Nuevas proteinas h5, moleculas de acido nucleico y vectores que las codifican y su uso medicinal.
MY162559A (en) Human anti-il-23 antibodies, compositions, methods and uses
ATE417595T1 (de) Keratin-bindende polypeptide
NZ595063A (en) Polypeptides from neisseria meningitidis
ATE519842T1 (de) Trichoderma reesei-glucoamylase und homologe davon
MX2008009886A (es) Anticuerpos que enlazan par-2.
ATE469911T1 (de) Isolierte nukleinsäuremoleküle die t-zellen induzierbare faktoren kodieren (tif), kodierte proteine und ihre anwendung
NO20063026L (no) Antistoffer
MX2010003055A (es) Nuevas citocinas aviares y secuencias geneticas que las codifican.
MX2012000133A (es) Quimera de adn polimerasa del fago phi29.
DE602007010969D1 (de) Zytokinderivate
ATE452141T1 (de) Neue proteine, z.b. zur verwendung für die in- vitro-isolierung und prävention von legionella pneumophila-infektionen
NZ589743A (en) Anxiolytic composition containing alphas1-casein-derived peptides
ATE441865T1 (de) Neue polypeptide zur in-vintro-isolierung und vorbeugung von infektionen mit legionella pneumophila
PL374550A1 (en) Il-17 like molecules and uses thereof
WO2006097432A3 (de) Keratin-biktdende desmoplakinpolypeptidsequenzen
ATE466876T1 (de) Immunogene konstrukte
GB0409559D0 (en) Polypeptide
KR20040053279A (ko) 스트레스 저항성 및 내성 단백질을 코딩하는 유전자
NZ593774A (en) Systems and methods for identifying Replikin scaffolds and uses of said Replikin scaffolds

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties